Broader Inclusion Criteria Could Double The Number Of Patients With Lung Cancer Eligible for Clinical Trials

The use of expanded eligibility criteria would allow nearly twice as many people with non-small cell lung cancer to participate in clinical trials, according to data presented at ASCO Annual Meeting. The study is the result of a joint project between ASCO and the nonprofit advocacy group Friends of Cancer Research, which issued recommendations for expanding clinical trial access. The retrospective study of 10,500 NSCLC patients used Real-World Data and analysis from ConcertAI.

Read More